Leading the Way in Life Science Technologies

GEN Exclusives

More »

GEN News Highlights

More »
November 3, 2006

Dutch Government Invests EUR 18M in TB Vaccine Development

  • The Dutch Ministry of Foreign Affairs  made a EUR 18.4-million, four-year investment in Aeras Global TB Vaccine Foundation, a product development partnership that is collaborating with Crucell, KNCV Tuberculosis Foundation, Netherlands Cancer Institute, and other Dutch organizations to develop new TB vaccines.

    In Aeras’ prime-boost strategy, an improved TB vaccine, the prime, will be given initially, and another type of vaccine, the boost, will be given at a specified period of time after the prime vaccination. One of the foundation’s products, Aeras 402/Crucell Adenovirus35 TB vaccine, recently entered clinical trials.

  • You’re all set! Thank you for subscribing to GEN Highlights.